Skip to main content
. 2019 May 24;20(10):2564. doi: 10.3390/ijms20102564

Figure 2.

Figure 2

Positron emission tomography (PET) imaging with 89Zr-DFO-9E7.4, 18F-FDG-PET and 89Zr-oxalate in tumor-bearing mice. Maximum intensity projections of PET and CT imaging at 24 h post-injection (PI) (A) of Mouse 1 showing uptake of a subcutaneous tumor (Tumors are indicated by red arrows). Maximum intensity projections of PET and CT imaging with 89Zr-oxalate at 24 h PI (C) of Mouse 10 showing low uptakes in both subcutaneous tumors while clearly visible on maximum intensity projections of 18F-FDG-PET and CT imaging (B).